Literature DB >> 4854667

The bioavailability in man of marketed brands of chlorpropamide.

A M Monro, P G Welling.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4854667     DOI: 10.1007/bf00614389

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  10 in total

1.  A method for the routine determination of chlorpropamide in plasma.

Authors:  R H CARMICHAEL
Journal:  Clin Chem       Date:  1959-12       Impact factor: 8.327

2.  The physical properties of chlorpropamide and its determination in human serum.

Authors:  T J TOOLAN; R L WAGNER
Journal:  Ann N Y Acad Sci       Date:  1959-03-30       Impact factor: 5.691

3.  Substitution for Brand-Name Drugs.

Authors:  S Caminetsky
Journal:  Can Med Assoc J       Date:  1963-05-04       Impact factor: 8.262

4.  Substitution for Brand-Named Drugs.

Authors:  A K Carter
Journal:  Can Med Assoc J       Date:  1963-01-12       Impact factor: 8.262

5.  Gas-liquid chromatographic estimation of tolbutamide and chlorpropamide in plasma.

Authors:  L F Prescott; D R Redman
Journal:  J Pharm Pharmacol       Date:  1972-09       Impact factor: 3.765

6.  The generic inequivalence of drugs.

Authors:  A B Varley
Journal:  JAMA       Date:  1968-11-18       Impact factor: 56.272

7.  Pharmacokinetics and biotransformation of chlorpropamide in man.

Authors:  J A Taylor
Journal:  Clin Pharmacol Ther       Date:  1972 Sep-Oct       Impact factor: 6.875

8.  Gas chromatographic method for determination of tolbutamide and chlorpropamide.

Authors:  K Sabih; K Sabih
Journal:  J Pharm Sci       Date:  1970-06       Impact factor: 3.534

9.  A study of the metabolic fate of chlorpropamide in man.

Authors:  P M Brotherton; P Grieveson; C McMartin
Journal:  Clin Pharmacol Ther       Date:  1969 Jul-Aug       Impact factor: 6.875

10.  Determination of tolbutamide and chlorpropamide in biological fluids.

Authors:  S B Matin; M Rowland
Journal:  J Pharm Pharmacol       Date:  1973-02       Impact factor: 3.765

  10 in total
  6 in total

1.  Plasma concentrations, bioavailability and dissolution of chlorpropamide.

Authors:  T Taylor; D F Assinder; L F Chasseaud; P M Bradford; J S Burton
Journal:  Eur J Clin Pharmacol       Date:  1977-03-11       Impact factor: 2.953

2.  Bioavailability of different preparations of paracetamol.

Authors:  A Richter; S E Smith
Journal:  Br J Clin Pharmacol       Date:  1974-12       Impact factor: 4.335

Review 3.  The relationship between the pharmacokinetics and pharmacodynamic effects of oral hypoglycaemic drugs.

Authors:  R E Ferner; S Chaplin
Journal:  Clin Pharmacokinet       Date:  1987-06       Impact factor: 6.447

4.  Bioavailability of chlorpropamide.

Authors:  M Evans; R C Glass; M Mitchard; B M Munday; R Yates
Journal:  Br J Clin Pharmacol       Date:  1979-01       Impact factor: 4.335

Review 5.  Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2.

Authors:  J E Jackson; R Bressler
Journal:  Drugs       Date:  1981-10       Impact factor: 9.546

Review 6.  Clinical pharmacokinetics of sulphonylurea hypoglycaemic drugs.

Authors:  L Balant
Journal:  Clin Pharmacokinet       Date:  1981 May-Jun       Impact factor: 6.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.